title: Fatal pulmonary embolism during liver transplantation.
authors.affiliation: University of California Los Angeles School of Medicine, USA.
authors.forename: M
authors.initials: M
authors.lastname: Sopher
authors.forename: M
authors.initials: M
authors.lastname: Braunfeld
authors.forename: C
authors.initials: C
authors.lastname: Shackleton
authors.forename: R W
authors.initials: RW
authors.lastname: Busuttil
authors.forename: S
authors.initials: S
authors.lastname: Sangwan
authors.forename: M
authors.initials: M
authors.lastname: Csete
mesh_terms: D000328:Adult; D015119:Aminocaproic Acid / Q000009:adverse effects; D000933:Antifibrinolytic Agents / Q000009:adverse effects; D007611:Aprotinin / Q000009:adverse effects; D006526:Hepatitis C / Q000601:surgery; D006801:Humans; D008103:Liver Cirrhosis / Q000601:surgery; D017093:Liver Failure / Q000601:surgery; D016031:Liver Transplantation; D008297:Male; D011655:Pulmonary Embolism / Q000209:etiology*; D015842:Serine Proteinase Inhibitors / Q000009:adverse effects
chemical_list: D000933:Antifibrinolytic Agents; D015842:Serine Proteinase Inhibitors; D007611:Aprotinin; D015119:Aminocaproic Acid